drugset / Trial / NCT05264805

Effectiveness of Port Site Bupivacaine Injection in Postoperative Pain Reduction After Lap. Chole

NCT05264805

Phase 3 Unknown 166 enrolled Hamdard University
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.

Timeline

Start
2022-03
Primary completion
2022-09
Completion
2022-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Subcutaneous
Subject Bupivacaine Other / unclassified 20 ml Subcutaneous

Indications